Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30239% above fair value
$4.54−0.12 (-2.58%)
Close on Nov 13, 2026Market cap $1.63BP/E 113.5Yield –
Precigen gross margin
Gross margin is gross profit as a percentage of revenue.
Precigen's gross margin for the twelve months ending Jun 30, 2018 was 82.9%. For fiscal 2017 it was 84.8%, against 80.2% the year before. The highest annual figure on record is 100.0% in fiscal 2012.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 84.8% | +4.6 |
| FY2016 | Dec 31, 2016 | 80.2% | +3.7 |
| FY2015 | Dec 31, 2015 | 76.5% | −8.1 |
| FY2014 | Dec 31, 2014 | 84.7% | −15.2 |
| FY2013 | Dec 31, 2013 | 99.9% | −0.1 |
| FY2012 | Dec 31, 2012 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | 75.1% | −8.6 |
| Q1 FY2018 | Mar 31, 2018 | 77.0% | −6.1 |
| Q4 FY2017 | Dec 31, 2017 | 90.1% | +8.0 |
| Q3 FY2017 | Sep 30, 2017 | 82.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 83.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 83.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 82.1% | – |
See a number that looks wrong?